Li Hai-shan, Liu Yong, Li Ding-feng, Zhang Ran-ran, Tang Hai-li, Zhang Yu-wei, Huang Wei, Liu Ying, Peng Hong, Xu Jian-qing, Hong Kun-xue, Shao Yi-ming
State Key Laboratory for Infectious Disease Prevention and Control, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 100050, China.
Chin Med J (Engl). 2007 Mar 20;120(6):496-502.
Although DNA vaccine is considered as the next generation of vaccine, most DNA vaccine candidates are still suffering from the relatively weak immunogenicity despite the increased dosage of plasmid DNA administered. In order to enhance the immune responses elicited by a codon-optimized HIV gag DNA vaccine, a modified plasmid vector pDRVI1.0 and a booster immunization with replicating Tiantan vaccinia (RTV) strain expressing the same gene were employed.
Vector pDRVI1.0 was constructed through inserting the 72-bp element from the SV40 enhancer, which was reported promoting nuclear transport of plasmid DNA, to the upstream of cytomegalovirus enhancer/promoter region of the plasmid vector pVR1012. Gene expression levels from expression plasmids based on pDRVI1.0 and pVR1012 were tested. Humoral and cellular immune responses induced by DNA vaccine alone or DNA prime-RTV boost regimen were determined in mice.
It was shown that the 72-bp element significantly enhanced the gene expression level in non-dividing cells. gag-specific humoral and cellular immune responses induced by DNA vaccination were both significantly improved, while the Th1/Th2 balance was not obviously affected by the 72-bp element. RTV boosting further significantly enhanced DNA vaccine-primed antibody and T cell responses in a Th1-biased manner.
The 72-bp SV40 enhancer element should be included in the DNA vaccine vector and RTV strain is a very efficient live vector for boosting immunization.
尽管DNA疫苗被视为下一代疫苗,但尽管增加了质粒DNA的给药剂量,大多数DNA疫苗候选物仍存在免疫原性相对较弱的问题。为了增强密码子优化的HIV gag DNA疫苗引发的免疫反应,采用了一种改良的质粒载体pDRVI1.0以及用表达相同基因的天坛痘苗病毒(RTV)株进行加强免疫。
通过将据报道可促进质粒DNA核转运的来自SV40增强子的72bp元件插入质粒载体pVR1012的巨细胞病毒增强子/启动子区域的上游,构建载体pDRVI1.0。检测基于pDRVI1.0和pVR1012的表达质粒的基因表达水平。在小鼠中测定单独的DNA疫苗或DNA初免-RTV加强免疫方案诱导的体液和细胞免疫反应。
结果表明,72bp元件显著提高了非分裂细胞中的基因表达水平。DNA疫苗接种诱导的gag特异性体液和细胞免疫反应均显著改善,而72bp元件对Th1/Th2平衡没有明显影响。RTV加强免疫进一步以Th1偏向的方式显著增强了DNA疫苗引发的抗体和T细胞反应。
DNA疫苗载体应包含72bp的SV40增强子元件,RTV株是一种非常有效的加强免疫活载体。